Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$7.56
-8.9%
$22.47
$5.26
▼
$31.97
$83.84M0.65481,965 shs205,366 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$394.40
+1.1%
$416.40
$274.84
▼
$450.69
$85.21B0.631.59 million shs2.04 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.99
+0.0%
$126.56
$66.51
▼
$133.06
$4.32B0.6772,869 shs798,710 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$319.12
-0.3%
$320.20
$279.69
▼
$362.41
$12.58B0.71568,338 shs205,408 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
-1.19%-15.22%-65.23%-68.83%+20.29%
Elevance Health, Inc. stock logo
ELV
Elevance Health
-2.62%-9.13%-11.08%-2.44%+23.37%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%+0.33%+0.21%+1.41%+87.87%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.18%-0.30%-1.38%-1.63%+12.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$7.56
-8.9%
$22.47
$5.26
▼
$31.97
$83.84M0.65481,965 shs205,366 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$394.40
+1.1%
$416.40
$274.84
▼
$450.69
$85.21B0.631.59 million shs2.04 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.99
+0.0%
$126.56
$66.51
▼
$133.06
$4.32B0.6772,869 shs798,710 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$319.12
-0.3%
$320.20
$279.69
▼
$362.41
$12.58B0.71568,338 shs205,408 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
-1.19%-15.22%-65.23%-68.83%+20.29%
Elevance Health, Inc. stock logo
ELV
Elevance Health
-2.62%-9.13%-11.08%-2.44%+23.37%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%+0.33%+0.21%+1.41%+87.87%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.18%-0.30%-1.38%-1.63%+12.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biodesix, Inc. stock logo
BDSX
Biodesix
2.86
Moderate Buy$34.20352.38% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.70
Moderate Buy$458.9116.36% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.08
Hold$113.67-10.49% Downside
Penumbra, Inc. stock logo
PEN
Penumbra
2.18
Hold$367.0715.02% Upside

Current Analyst Ratings Breakdown

Latest ITGR, BDSX, ELV, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
UpgradeHold ➝ Buy$510.00
11/17/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Reiterated RatingHold$374.00
11/11/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Reiterated RatingHold (C)
11/9/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
Lower Price TargetBuy$38.00 ➝ $34.00
11/6/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
Lower Price TargetBuy$40.00 ➝ $30.00
11/4/2026
Integer Holdings Corporation stock logo
ITGR
Integer
DowngradeHold (C+) ➝ Hold (C)
10/30/2026
Penumbra, Inc. stock logo
PEN
Penumbra
UpgradeHold (C) ➝ Hold (C+)
10/27/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Boost Price TargetOverweight$473.00 ➝ $492.00
10/23/2026
Integer Holdings Corporation stock logo
ITGR
Integer
UpgradeHold (C) ➝ Hold (C+)
10/23/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Set Price Target$490.00
10/23/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Reiterated RatingNeutral$451.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biodesix, Inc. stock logo
BDSX
Biodesix
$88.50M0.95N/AN/A$0.78 per share9.69
Elevance Health, Inc. stock logo
ELV
Elevance Health
$201.83B0.42$36.96 per share10.67$207.33 per share1.90
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.33$10.37 per share12.25$50.78 per share2.50
Penumbra, Inc. stock logo
PEN
Penumbra
$1.40B8.96$4.28 per share74.58$40.18 per share7.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biodesix, Inc. stock logo
BDSX
Biodesix
-$35.26M-$2.76N/AN/AN/A-25.74%-442.34%-29.16%N/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.66B$23.4516.8213.141.912.55%14.97%5.31%1/27/2027 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$2.9842.6118.932.415.68%11.84%5.98%N/A
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$3.9780.3852.75N/A10.06%10.39%8.09%N/A

Latest ITGR, BDSX, ELV, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.7486-$0.75-$0.0014-$0.75$27.48 million$24.04 million
10/29/2026Q3 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.68$1.34-$0.34$0.43$456.91 million$449.66 million
10/29/2026Q3 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.20$1.07-$0.13$1.07$401.41 million$410.15 million
10/21/2026Q3 2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
$4.71$6.99+$2.28$6.27$49.28 billion$50.44 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.881.74%+12.47%29.34%14 Years
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A

Latest ITGR, BDSX, ELV, and PEN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/20/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.721.58%12/4/202612/4/202612/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biodesix, Inc. stock logo
BDSX
Biodesix
5.43
2.96
2.96
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.68
1.47
1.47
Integer Holdings Corporation stock logo
ITGR
Integer
0.73
3.98
2.60
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
5.89
3.92

Institutional Ownership

CompanyInstitutional Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%

Insider Ownership

CompanyInsider Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
23.20%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.34%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
33411.09 million8.52 millionNo Data
Elevance Health, Inc. stock logo
ELV
Elevance Health
97,100216.06 million215.32 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00034.00 million33.62 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.41 million38.27 millionOptionable

Recent News About These Companies

Boston Scientific prices $3 billion and €4.25 billion notes
Penumbra (NYSE:PEN) Given "Hold" Rating at Canaccord Genuity Group
Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny
Penumbra Inc. Q3 Income Drops
MarketBeat cites USD 367.07 target for Penumbra stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biodesix stock logo

Biodesix NASDAQ:BDSX

$7.56 -0.74 (-8.92%)
Closing price 04:00 PM Eastern
Extended Trading
$7.63 +0.07 (+0.94%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Elevance Health stock logo

Elevance Health NYSE:ELV

$394.40 +4.24 (+1.09%)
Closing price 03:59 PM Eastern
Extended Trading
$406.05 +11.64 (+2.95%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Integer stock logo

Integer NYSE:ITGR

$126.99 +0.02 (+0.02%)
Closing price 11/16/2026 04:24 PM Eastern
Extended Trading
$126.99 0.00 (0.00%)
As of 11/16/2026 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Penumbra stock logo

Penumbra NYSE:PEN

$319.12 -0.89 (-0.28%)
Closing price 03:59 PM Eastern
Extended Trading
$319.15 +0.03 (+0.01%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.